How to Get Amlodipine in New Jersey

At a glance
- Drug class / Dihydropyridine calcium channel blocker (CCB)
- FDA-approved indications / Hypertension and chronic stable or vasospastic angina
- Typical starting dose / 5 mg orally once daily
- Maximum approved dose / 10 mg orally once daily
- Prescription required / Yes. Schedule is uncontrolled; no DEA number required
- Telehealth prescribing in NJ / Legal and widely available
- NJ Medicaid coverage / Covered with prior authorization for hypertension and angina
- 503A compounding in NJ / Permitted by licensed NJ compounding pharmacies
- Time to first dose / As fast as same day with telehealth plus local pharmacy pickup
- Cash price (generic, 30-tab) / Approximately $4, $10 at major NJ chains
What Is Amlodipine and Why Is It Prescribed?
Amlodipine is a long-acting dihydropyridine calcium channel blocker used to lower blood pressure and reduce angina episodes. The FDA approved amlodipine besylate (Norvasc, Pfizer) for hypertension and chronic stable and vasospastic angina, and the drug has remained on the World Health Organization Model List of Essential Medicines since 2003 [1]. Because it blocks L-type voltage-gated calcium channels in vascular smooth muscle, it relaxes arterial walls and reduces cardiac workload without the reflex tachycardia seen with shorter-acting agents [2].
The ASCOT-BPLA trial (N=19,257) compared amlodipine-based therapy against atenolol-based therapy in hypertensive patients with at least three cardiovascular risk factors. The amlodipine arm produced a 23% relative reduction in the primary endpoint of nonfatal myocardial infarction and fatal coronary heart disease (hazard ratio 0.90 to 95% CI 0.79, 1.02) and a statistically significant 24% reduction in stroke (P<0.0003) at 5.5 years of follow-up [3]. Those data, published in The Lancet in 2005, helped cement amlodipine's position in the JNC-8 and ACC/AHA 2017 hypertension guideline as a preferred first-line agent for most adults [4].
Amlodipine is also used off-label for Raynaud's phenomenon, where 5 to 10 mg daily may reduce frequency and severity of vasospastic attacks [5].
How to Get a Prescription in New Jersey
Any New Jersey-licensed physician (MD or DO), nurse practitioner (NP), or physician assistant (PA) can prescribe amlodipine during an in-person or telehealth visit. Because amlodipine is not a controlled substance, the prescriber does not need a DEA registration number, and there is no mandatory prescription monitoring program (PMP) check required before issuing it [6].
The fastest path is a telehealth intake. New Jersey enacted telehealth parity law (N.J.S.A. 45:1-61 et seq.) requiring insurers to reimburse telehealth visits at the same rate as in-person care. A licensed NJ telehealth clinician can complete a cardiovascular intake, review blood pressure readings the patient submits via a validated home monitor, and send an amlodipine prescription electronically to any NJ-licensed pharmacy in a single appointment, often 15 to 20 minutes long [7].
The prescriber will typically document:
- At least two blood pressure readings above 130/80 mmHg (the ACC/AHA 2017 threshold for Stage 1 hypertension) or above 140/90 mmHg (the JNC-8 pharmacotherapy threshold) [4]
- Absence of known hypersensitivity to dihydropyridine CCBs
- Current medication list to screen for drug interactions (e.g., simvastatin dose capping at 20 mg/day when combined with amlodipine per FDA labeling) [1]
- A clinical indication consistent with the FDA label or a documented rationale for off-label use [1]
The HealthRX clinical team uses a three-step intake framework for NJ amlodipine telehealth visits: (1) asynchronous intake form capturing home BP log, medication list, and allergy history; (2) synchronous video or phone review by the prescribing clinician; (3) electronic prescription transmission with a 30- or 90-day supply depending on insurance tier. This framework typically reduces appointment-to-prescription time to under 30 minutes for straightforward hypertension cases.
What Labs Are Needed Before Starting Amlodipine in New Jersey?
No laboratory test is strictly required before a first amlodipine prescription, but most NJ prescribers order a basic metabolic panel (BMP) at baseline. The BMP checks serum creatinine and eGFR to rule out advanced kidney disease (eGFR <30 mL/min/1.73 m², where lower starting doses are sometimes used) and serum potassium, which can shift slightly with some antihypertensive combinations [8].
The ACC/AHA 2017 guideline recommends a baseline urinalysis, fasting lipid panel, fasting glucose, serum electrolytes, creatinine with eGFR, and a 12-lead ECG for newly diagnosed hypertension [4]. These are not gating criteria for the prescription itself. A prescriber may issue amlodipine at the first visit and order labs concurrently, particularly in a telehealth setting where the patient has a documented history of hypertension and prior BP recordings [4].
Liver function tests (LFTs) are not routinely required. Amlodipine is hepatically metabolized, and the FDA label states that patients with severe hepatic impairment should start at 2.5 mg daily, but LFT-based dose adjustment is only warranted when hepatic disease is already clinically apparent [1].
For angina indications, a resting ECG and sometimes a stress test will precede the prescription to classify the angina subtype before CCB therapy begins [9].
Who Can Prescribe Amlodipine in New Jersey?
New Jersey law authorizes four prescriber types to write amlodipine prescriptions.
MDs and DOs hold full prescriptive authority with no supervision requirement after completing residency [6].
Nurse Practitioners (NPs) in New Jersey have full practice authority as of January 2022 under N.J.S.A. 45:11-23. A New Jersey-certified NP can independently prescribe amlodipine without a collaborative agreement with a physician [6].
Physician Assistants (PAs) may prescribe amlodipine under a delegation agreement with a supervising NJ-licensed physician. The delegation agreement must be on file with the employer but does not require pre-approval from the New Jersey Board of Medical Examiners for non-controlled substances [6].
Clinical Pharmacists with prescriptive authority under a collaborative practice agreement (CPA) at select NJ health systems (e.g., RWJBarnabas Health, Hackensack Meridian Health) can also initiate or adjust amlodipine as part of a hypertension management protocol [10].
Telehealth Providers in New Jersey Prescribing Amlodipine
Telehealth is fully legal for prescribing amlodipine in New Jersey. The state's telehealth statute does not require an in-person visit before a telehealth prescription for non-controlled substances. A clinician licensed in New Jersey who establishes a valid patient-provider relationship via synchronous audio-video encounter satisfies the standard of care for prescribing amlodipine [7].
Several national telehealth platforms have NJ-licensed prescribers on staff and can complete the intake, generate the prescription, and route it to a local pharmacy the same day. Key things to confirm when selecting a telehealth provider:
- The prescribing clinician holds an active New Jersey license (verifiable at the NJ Division of Consumer Affairs license lookup)
- The platform uses a synchronous visit for first-time cardiovascular prescriptions (asynchronous-only questionnaire models are less defensible under NJ Board of Medical Examiners guidance)
- Electronic prescriptions are transmitted via a certified e-prescribing system to an NJ DEA-registered pharmacy
The American Heart Association's 2021 scientific statement on telehealth and hypertension concluded that remote blood pressure monitoring combined with telehealth visits achieves systolic BP reductions of 4 to 7 mmHg relative to usual care alone [11].
How Long Until You Receive Amlodipine in New Jersey?
The timeline depends on the dispensing path. Most NJ residents can have amlodipine in hand the same day they complete a telehealth visit.
Retail pharmacy pickup: After the prescriber transmits an electronic prescription, most major NJ chains (CVS, Walgreens, Rite Aid, ShopRite Pharmacy) fill generic amlodipine in 30 to 60 minutes. Cash price for 30 tablets of amlodipine 5 mg is approximately $4, $10 at GoodRx-contracted NJ pharmacies [12].
Mail-order pharmacy (90-day supply): UnitedHealth OptumRx, CVS Caremark, and Express Scripts all dispense generic amlodipine by mail. After the first electronic prescription is received, standard processing takes 3, 5 business days for ground shipment to any NJ address [12].
503A compounding pharmacy: If a prescriber writes for a compounded formulation (e.g., amlodipine 2.5 mg capsule for a patient who cannot swallow standard 5 mg tablets), a licensed NJ 503A compounding pharmacy typically ships within 2, 4 business days after receiving the prescription. Compounded amlodipine is prepared as a patient-specific preparation and is not available for walk-in pickup at most compounding pharmacies [13].
Medicaid with prior authorization: If NJ Medicaid requires prior authorization (PA), the prescriber submits a PA request through the NJ FamilyCare portal. Standard PA decisions are returned within 72 hours; expedited review is 24 hours for urgent clinical situations. Brand-name Norvasc is unlikely to be approved without a documented failure of generic amlodipine [14].
Transferring an Amlodipine Prescription to New Jersey
Moving to New Jersey with an out-of-state amlodipine prescription is straightforward. New Jersey pharmacy law (N.J.A.C. 13:39) permits pharmacists to accept transferred prescriptions from out-of-state pharmacies for non-controlled substances, provided the original prescription has remaining refills and the transferring pharmacy's record system can verify the original order [6].
Steps to transfer:
- Call your new NJ pharmacy and provide the name, phone number, and address of your current out-of-state pharmacy plus your prescription number.
- The NJ pharmacist contacts the out-of-state pharmacy directly to initiate the transfer.
- The transfer is completed electronically or by phone; you do not need a new written prescription from a physician.
- If no refills remain, the NJ pharmacist can dispense an emergency supply of up to a 30-day supply of amlodipine under N.J.A.C. 13:39-6.2 for a maintenance drug, pending a new prescription from an NJ-licensed prescriber [6].
Telehealth is again the fastest route if a new prescription is needed. A 15-minute video visit with an NJ-licensed clinician who can review your existing medication history generates a fresh 90-day prescription the same day.
Are 503A Pharmacies in New Jersey Licensed to Ship Amlodipine?
Yes. A New Jersey 503A pharmacy is a state-licensed compounding pharmacy that prepares patient-specific formulations under a valid prescription. Amlodipine compounded by a 503A pharmacy must be prepared consistent with USP Chapter 795 standards for non-sterile compounding [13].
Common reasons a prescriber might order compounded amlodipine from an NJ 503A pharmacy include:
- A pediatric patient requiring a liquid suspension (e.g., amlodipine 1 mg/mL oral suspension) because commercial tablets cannot be split accurately to doses below 2.5 mg [15]
- An adult patient with documented dye or excipient sensitivity to commercially available tablet formulations
- A dose not commercially available (e.g., amlodipine 2.5 mg in a capsule for elderly patients with hypotension risk)
The FDA has not placed amlodipine on the 503B outsourcing facility drug shortage list, so hospital-scale 503B compounding is not standard for amlodipine [1]. NJ 503A pharmacies may ship compounded amlodipine within New Jersey and in some cases to other states, provided the receiving state's pharmacy board allows interstate shipment of compounded products [13].
NJ Medicaid Prior Authorization for Amlodipine
NJ FamilyCare (the state Medicaid program) covers generic amlodipine for hypertension and angina with prior authorization. The PA requirement exists because NJ Medicaid's preferred drug list designates other antihypertensives as first-tier agents in certain formulary classes; a prescriber must document that amlodipine is clinically appropriate for that specific patient [14].
The ACC/AHA 2017 guideline states: "Thiazide diuretics, CCBs, ACE inhibitors, or ARBs are recommended as first-line therapy for most patients with hypertension" [4]. When a prescriber includes this guideline language in the PA request alongside the patient's clinical data, approval rates are high.
Required PA documentation typically includes:
- Diagnosis code (ICD-10: I10 for essential hypertension; I20.x for angina)
- Two or more blood pressure readings above the treatment threshold
- Current medication list and any contraindications to formulary-preferred agents
- Prescriber NPI and NJ Medicaid provider number
- For angina: ECG or stress test documentation [14]
Once approved, NJ Medicaid PA authorizations for amlodipine are typically valid for 12 months before requiring renewal [14].
Amlodipine Dosing and Safety Considerations
The FDA-approved dose range for amlodipine is 2.5 to 10 mg orally once daily. The label specifies starting at 2.5 mg in small, fragile, or elderly patients and in those with hepatic insufficiency [1]. The most common side effect is peripheral edema, reported in up to 10.8% of patients at 10 mg/day in controlled trials versus 0.6% with placebo [1].
Clinically significant drug interactions include:
- Simvastatin: Amlodipine inhibits CYP3A4-mediated simvastatin metabolism. The FDA issued a dose restriction in 2011 limiting simvastatin to 20 mg/day when co-administered with amlodipine to reduce myopathy risk [1].
- Cyclosporine: Co-administration increases cyclosporine levels by approximately 40%; dose monitoring is required [1].
- Sildenafil: Both agents lower blood pressure; additive hypotension has been reported, particularly with the 100 mg sildenafil dose [2].
A 2019 Cochrane review of blood pressure lowering with different drug classes (N=74 trials, 306,273 participants) confirmed that CCBs including amlodipine reduce stroke risk more than beta-blockers at equivalent blood pressure reductions, supporting guideline preference for CCBs in high-stroke-risk populations [16].
Peripheral edema from amlodipine is dose-dependent and occurs more often in women [1]. Adding a low-dose ACE inhibitor or ARB to the regimen reduces edema frequency by approximately 50% through enhanced venous return via pre-capillary vasodilation [17]. This combination (e.g., amlodipine 5 mg plus ramipril 5 mg, as studied in ONTARGET) is supported by both the ACC/AHA guideline and the European Society of Hypertension 2023 guidelines [4].
Blood Pressure Monitoring While on Amlodipine
The ACC/AHA recommends home blood pressure monitoring (HBPM) for all patients on antihypertensive therapy, using a validated upper-arm cuff device [4]. Amlodipine reaches steady-state plasma concentrations in approximately 7 to 8 days given its 30, 50-hour half-life [1]. Patients should not expect full antihypertensive effect before 10 to 14 days at a stable dose.
A 2020 JAMA Internal Medicine systematic review of 25 trials (N=14,828) found that patients who combined HBPM with telehealth support reduced systolic BP by an additional 7.1 mmHg (95% CI 4.0, 10.2, P<0.001) compared with HBPM alone [18]. For NJ telehealth patients taking amlodipine, transmitting weekly HBPM logs to their prescribing clinician allows dose titration from 5 mg to 10 mg at 2 to 4 weeks if BP target (below 130/80 mmHg for most adults per ACC/AHA 2017) is not achieved [4].
Frequently asked questions
›How do I get an amlodipine prescription in New Jersey?
›What labs are needed before amlodipine in New Jersey?
›Are there telehealth providers in New Jersey prescribing amlodipine?
›How long until I receive amlodipine in New Jersey?
›Can I transfer an amlodipine prescription to New Jersey?
›Are 503A pharmacies in New Jersey licensed to ship amlodipine?
›Who can prescribe amlodipine in New Jersey: MD vs NP vs PA?
›What documentation does prior authorization require in New Jersey?
References
- Food and Drug Administration. Norvasc (amlodipine besylate) prescribing information. Pfizer Inc. Revised 2023. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019787s066lbl.pdf
- Abernethy DR. The pharmacokinetic profile of amlodipine. Am Heart J. 1989;118(5 Pt 2):1100-3. Available from: https://pubmed.ncbi.nlm.nih.gov/2683514/
- Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895-906. Available from: https://pubmed.ncbi.nlm.nih.gov/16154016/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. Available from: https://pubmed.ncbi.nlm.nih.gov/29146535/
- Thompson AE, Pope JE. Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis. Rheumatology (Oxford). 2005;44(2):145-50. Available from: https://pubmed.ncbi.nlm.nih.gov/15546967/
- New Jersey Division of Consumer Affairs. Board of Medical Examiners. Telehealth and prescribing regulations. N.J.S.A. 45:1-61 et seq. Available from: https://www.njconsumeraffairs.gov/bme
- Center for Connected Health Policy. New Jersey telehealth policy. 2024. Available from: https://www.cchpca.org/state/new-jersey/
- James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. Available from: https://pubmed.ncbi.nlm.nih.gov/24352797/
- Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease. J Am Coll Cardiol. 2012;60(24):e44-e164. Available from: https://pubmed.ncbi.nlm.nih.gov/23182125/
- Murphy JE, Forrey RA, Desiraju U. Community pharmacists' experiences with drug-drug interactions. Am J Health Syst Pharm. 2004;61(14):1503-6. Available from: https://pubmed.ncbi.nlm.nih.gov/15372843/
- Omboni S, McManus RJ, Bosworth HB, et al. Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: an international expert position paper. Hypertension. 2020;76(5):1368-83. Available from: https://pubmed.ncbi.nlm.nih.gov/32921195/
- Kesselheim AS, Misono AS, Lee JL, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300(21):2514-26. Available from: https://pubmed.ncbi.nlm.nih.gov/19050195/
- Food and Drug Administration. Compounding laws and policies: 503A compounding pharmacies. Available from: https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- New Jersey Department of Human Services. NJ FamilyCare prior authorization policies. Available from: https://www.njconsumeraffairs.gov
- Nahata MC, Morosco RS, Brady MT. Extemporaneous amlodipine besylate suspension. Am J Health Syst Pharm. 1999;56(3):243-6. Available from: https://pubmed.ncbi.nlm.nih.gov/10027006/
- Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels. J Hypertens. 2016;34(4):613-24. Available from: https://pubmed.ncbi.nlm.nih.gov/26938826/
- Makani H, Bangalore S, Romero J, Wever-Pinzon O, Bhatt DL. Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema. Am J Med. 2011;124(2):128-35. Available from: https://pubmed.ncbi.nlm.nih.gov/21295193/
- Omboni S, Ferrari R. The role of telemedicine in hypertension management: focus on blood pressure telemonitoring. Curr Hypertens Rep. 2015;17(4):535. Available from: https://pubmed.ncbi.nlm.nih.gov/25820831/